期刊文献+

大鼠血浆中洛伐他汀的HPLC测定及药动学研究 被引量:4

Determination of Lovastatin in Rat Plasma by HPLC and Its Pharmacokinetics Study
原文传递
导出
摘要 目的:探索采用高效液相色谱法测定大鼠血浆中洛伐他汀浓度的方法。方法:血浆样品采用环已烷-二氯甲烷(3.5:1,V/V)提取,HPLC条件为色谱柱采用XTerra(?)MSC18柱(150×2.1 mm,5μm),流动相为乙腈-水(63L37,V/V),柱温35℃,检测波长为238nm。结果:大鼠血浆中洛伐他汀在0.01~5μg/mL线性范围内线性关系良好,最低检测浓度为0.01~g/mL,方法的提取回收率为81%~95%,日内、日间RSD均小于9.55%;药代动力学结果表明洛伐他汀在雌雄大鼠体内的Tp、Cmax和AUC均有显著性差异(p<0.05)。结论:建立的HPLC方法简便、灵敏度高,重现性好,药动学研究表明洛伐他汀在大鼠体内存在性别差异。 Objective: To investigate the determination of Lovastatin by HPLC in rats after oral single dose. Methods The plasma samples were extracted by cyclohexane-dichloromethane (3.5:1, V/V). The condition of HPLC: the analytical column was XTerra MS C18 (150× 2.1 mm, 5 μm). The mobile phase was acetonitrile-water (63: 37, V/V). The temperature of column was 35 ℃. The compounds were quantified by using an ultraviolet detector operated at 238 nm. Results: The linear correlation of rat plasma lovastatin was good in range of 0.01-5μg/mL. The limit density of detection was 0.01 μg/mL, and the extraction recovery rate was between 81% and 95 %. The phannacokinetics parameter of lovastatin in rats: Tp, Cmax and AUC0-10 were obviously different in different sex rats(p〈0. 05). Conclusion: This analytical method is simple, high sensitive and high reduplicative enough. The study showed that there were sex differences of lovastatin in rats.
出处 《现代生物医学进展》 CAS 2008年第12期2533-2535,共3页 Progress in Modern Biomedicine
基金 国家高技术研究发展(863)计划项目(2006AA090401)
关键词 洛伐他汀 高效液相色谱 血药浓度 Lovastatin HPLC Plasma
  • 相关文献

参考文献4

二级参考文献13

  • 1何璧梅,姚国柱,张辉,徐寅正,隆泉.血脂调节剂的研究——Ⅰ.HMG-CoA还原酶抑制剂M-8614A及MH-2688B产生菌的筛选[J].中国抗生素杂志,1993,18(2):136-139. 被引量:12
  • 2Pearson TA, Mart HJ. The rapid reduction in cardiac events with lipip lowering therapy:mechanisms and implication[J]. Am J Cardial, 1993, 72 : 1072 - 1073. 被引量:1
  • 3Holme I. An analysis of randomized trials evaluating; the effect of cholesterol reduction on total mortality and coronary heart disease indicence[J]. Circulation, 1990, 82:1916 - 1924. 被引量:1
  • 4Bilheime DW. Therapeutic control of hyperlipidemia in the prevention of coronary atherosclerosis: A review of resultls from recent clinical trails[J]. Am J Cardiol, 1988, 62 : 1 - 9. 被引量:1
  • 5Roman K, Ivashkiv E, Arnold ME, et al. Determination of prvasatin Sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative jon chemical ionization mass spectrometry[J]. Biomedd Environmental Mass Spectrum, 1989,18: 90 - 906. 被引量:1
  • 6Stubbs RJ, Schwartz M, Bayne WF. Determination of mevinolin and mevinolic acid in plasma and bile by reversedphase high performance liquid chromatography[ J ]. Chromatogr Biomed Appl, 1998,383(2):483 - 485. 被引量:1
  • 7Roman K, Vladimir K. Determinition of lovastatin (mevinolin)and mevinolinic acid in fevmentation liquids [J ]. Chromatogr, 1993,630:415 -417. 被引量:1
  • 8Carlucci. pharmaceutical and Biomedical[J ]. Anaglysis. 1992,10(9) :693. 被引量:1
  • 9Carlucci. pharmaceutical and Biomedical[J]. Anaglysis.1992,10(9):693. 被引量:1
  • 10赵飞浪,袁倚盛,沈学英.RP-HPLC测定人血浆中洛伐他汀浓度及药动学研究[J].中国药科大学学报,1997,28(5):288-290. 被引量:12

共引文献22

同被引文献19

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部